

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.94779759 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.94779759 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.60014244 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.60014244 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.12951763 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.92819591 |
| 7 | glyoxylate metabolic process (GO:0046487) | 4.74472732 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.73368325 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 4.62726023 |
| 10 | lysine catabolic process (GO:0006554) | 4.61995903 |
| 11 | lysine metabolic process (GO:0006553) | 4.61995903 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.61693983 |
| 13 | complement activation, alternative pathway (GO:0006957) | 4.56687899 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.53274403 |
| 15 | urea metabolic process (GO:0019627) | 4.47425523 |
| 16 | urea cycle (GO:0000050) | 4.47425523 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.47083590 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.47083590 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.47083590 |
| 20 | cysteine metabolic process (GO:0006534) | 4.46507456 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.45186646 |
| 22 | regulation of protein activation cascade (GO:2000257) | 4.39822403 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.32217436 |
| 24 | protein carboxylation (GO:0018214) | 4.32217436 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.22219590 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 4.19477772 |
| 27 | regulation of complement activation (GO:0030449) | 4.16919887 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.09990399 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.09861178 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.07704323 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 4.04494731 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.98531370 |
| 33 | bile acid metabolic process (GO:0008206) | 3.97741831 |
| 34 | homocysteine metabolic process (GO:0050667) | 3.93418419 |
| 35 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.90306483 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 3.88991753 |
| 37 | regulation of fibrinolysis (GO:0051917) | 3.82325712 |
| 38 | bile acid and bile salt transport (GO:0015721) | 3.78637373 |
| 39 | acylglycerol homeostasis (GO:0055090) | 3.78206322 |
| 40 | triglyceride homeostasis (GO:0070328) | 3.78206322 |
| 41 | fatty acid transmembrane transport (GO:1902001) | 3.74881422 |
| 42 | fatty acid beta-oxidation (GO:0006635) | 3.74021105 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 3.73123203 |
| 44 | regulation of actin filament-based movement (GO:1903115) | 3.71974094 |
| 45 | acetyl-CoA metabolic process (GO:0006084) | 3.71822344 |
| 46 | ethanol oxidation (GO:0006069) | 3.71739284 |
| 47 | coenzyme catabolic process (GO:0009109) | 3.67687951 |
| 48 | aspartate family amino acid catabolic process (GO:0009068) | 3.65938110 |
| 49 | fatty acid oxidation (GO:0019395) | 3.64606366 |
| 50 | short-chain fatty acid metabolic process (GO:0046459) | 3.64049865 |
| 51 | drug catabolic process (GO:0042737) | 3.63159169 |
| 52 | aromatic amino acid family metabolic process (GO:0009072) | 3.60700860 |
| 53 | lipid oxidation (GO:0034440) | 3.58012999 |
| 54 | reverse cholesterol transport (GO:0043691) | 3.57887468 |
| 55 | plasma lipoprotein particle remodeling (GO:0034369) | 3.57364716 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 3.57364716 |
| 57 | macromolecular complex remodeling (GO:0034367) | 3.57364716 |
| 58 | regulation of bile acid biosynthetic process (GO:0070857) | 3.53895753 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 3.53648423 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 3.53360821 |
| 61 | carnitine shuttle (GO:0006853) | 3.52886442 |
| 62 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.51712354 |
| 63 | 2-oxoglutarate metabolic process (GO:0006103) | 3.51680025 |
| 64 | phospholipid homeostasis (GO:0055091) | 3.50186049 |
| 65 | fatty acid catabolic process (GO:0009062) | 3.49870216 |
| 66 | tyrosine metabolic process (GO:0006570) | 3.49541875 |
| 67 | cell communication involved in cardiac conduction (GO:0086065) | 3.49444899 |
| 68 | ketone body metabolic process (GO:1902224) | 3.47028475 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 3.45276734 |
| 70 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.43463678 |
| 71 | regulation of cell communication by electrical coupling (GO:0010649) | 3.40848854 |
| 72 | phospholipid efflux (GO:0033700) | 3.39847060 |
| 73 | monocarboxylic acid catabolic process (GO:0072329) | 3.38053413 |
| 74 | cellular sodium ion homeostasis (GO:0006883) | 3.35274872 |
| 75 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.33888910 |
| 76 | biotin metabolic process (GO:0006768) | 3.33125996 |
| 77 | regulation of sequestering of triglyceride (GO:0010889) | 3.31121707 |
| 78 | cellular glucuronidation (GO:0052695) | 3.29399197 |
| 79 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.29019228 |
| 80 | regulation of cholesterol esterification (GO:0010872) | 3.28964839 |
| 81 | positive regulation of lipid catabolic process (GO:0050996) | 3.28020529 |
| 82 | glutamate metabolic process (GO:0006536) | 3.27770039 |
| 83 | cholesterol efflux (GO:0033344) | 3.27424062 |
| 84 | organic acid catabolic process (GO:0016054) | 3.27264831 |
| 85 | carboxylic acid catabolic process (GO:0046395) | 3.27264831 |
| 86 | negative regulation of lipase activity (GO:0060192) | 3.24495551 |
| 87 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.23866358 |
| 88 | sodium ion export (GO:0071436) | 3.21985977 |
| 89 | benzene-containing compound metabolic process (GO:0042537) | 3.19350248 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.19334490 |
| 91 | carnitine metabolic process (GO:0009437) | 3.19261196 |
| 92 | regulation of relaxation of muscle (GO:1901077) | 3.17728124 |
| 93 | negative regulation of protein activation cascade (GO:2000258) | 3.17303542 |
| 94 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.16941687 |
| 95 | sterol homeostasis (GO:0055092) | 3.16872059 |
| 96 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.14916490 |
| 97 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.14916490 |
| 98 | arginine metabolic process (GO:0006525) | 3.13833121 |
| 99 | cell communication by electrical coupling (GO:0010644) | 3.12413805 |
| 100 | regulation of cholesterol metabolic process (GO:0090181) | 3.11627705 |
| 101 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.11506760 |
| 102 | negative regulation of cholesterol transport (GO:0032375) | 3.11233283 |
| 103 | negative regulation of sterol transport (GO:0032372) | 3.11233283 |
| 104 | cellular potassium ion homeostasis (GO:0030007) | 3.10694299 |
| 105 | fibrinolysis (GO:0042730) | 3.10413330 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 3.10075673 |
| 107 | positive regulation of fatty acid oxidation (GO:0046321) | 3.09654414 |
| 108 | valine metabolic process (GO:0006573) | 3.08923436 |
| 109 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.08204825 |
| 110 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.07419512 |
| 111 | indolalkylamine metabolic process (GO:0006586) | 3.07205668 |
| 112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.06568669 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.06568669 |
| 114 | muscle filament sliding (GO:0030049) | 3.05905302 |
| 115 | actin-myosin filament sliding (GO:0033275) | 3.05905302 |
| 116 | branched-chain amino acid catabolic process (GO:0009083) | 3.04840470 |
| 117 | complement activation (GO:0006956) | 3.04557911 |
| 118 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.03662991 |
| 119 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.02670055 |
| 120 | complement activation, classical pathway (GO:0006958) | 3.00697787 |
| 121 | relaxation of cardiac muscle (GO:0055119) | 2.96836231 |
| 122 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.95694883 |
| 123 | cardiac muscle contraction (GO:0060048) | 2.91379632 |
| 124 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.90633643 |
| 125 | myofibril assembly (GO:0030239) | 2.87871886 |
| 126 | sarcomere organization (GO:0045214) | 2.87582946 |
| 127 | sodium ion homeostasis (GO:0055078) | 2.79801520 |
| 128 | cardiac muscle hypertrophy (GO:0003300) | 2.76314113 |
| 129 | cardiac myofibril assembly (GO:0055003) | 2.75339213 |
| 130 | actin-mediated cell contraction (GO:0070252) | 2.70776152 |
| 131 | potassium ion import (GO:0010107) | 2.68012957 |
| 132 | striated muscle contraction (GO:0006941) | 2.65475412 |
| 133 | striated muscle hypertrophy (GO:0014897) | 2.62656681 |
| 134 | intestinal cholesterol absorption (GO:0030299) | 2.61793714 |
| 135 | desmosome organization (GO:0002934) | 2.61781639 |
| 136 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.56269005 |
| 137 | cardiac muscle cell action potential (GO:0086001) | 2.52357110 |
| 138 | regulation of lipoprotein metabolic process (GO:0050746) | 2.50086004 |
| 139 | axon ensheathment in central nervous system (GO:0032291) | 2.48911252 |
| 140 | central nervous system myelination (GO:0022010) | 2.48911252 |
| 141 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.45335270 |
| 142 | NADH metabolic process (GO:0006734) | 2.44130267 |
| 143 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.43568441 |
| 144 | actomyosin structure organization (GO:0031032) | 2.43519688 |
| 145 | detection of calcium ion (GO:0005513) | 2.41020107 |
| 146 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.40932708 |
| 147 | negative regulation of complement activation (GO:0045916) | 2.39968395 |
| 148 | polyketide metabolic process (GO:0030638) | 2.39072164 |
| 149 | doxorubicin metabolic process (GO:0044598) | 2.39072164 |
| 150 | daunorubicin metabolic process (GO:0044597) | 2.39072164 |
| 151 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.37896455 |
| 152 | positive regulation of sodium ion transport (GO:0010765) | 2.37791059 |
| 153 | glutamate secretion (GO:0014047) | 2.37100712 |
| 154 | negative regulation of hormone metabolic process (GO:0032351) | 2.37094273 |
| 155 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.36847430 |
| 156 | cardiac conduction (GO:0061337) | 2.36695829 |
| 157 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.34408230 |
| 158 | artery smooth muscle contraction (GO:0014824) | 2.32736830 |
| 159 | actin filament-based movement (GO:0030048) | 2.32045625 |
| 160 | regulation of striated muscle contraction (GO:0006942) | 2.31985606 |
| 161 | regulation of the force of heart contraction (GO:0002026) | 2.31921463 |
| 162 | negative regulation of protein localization to cell surface (GO:2000009) | 2.30200347 |
| 163 | relaxation of muscle (GO:0090075) | 2.30185469 |
| 164 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.29126835 |
| 165 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.26736596 |
| 166 | potassium ion homeostasis (GO:0055075) | 2.26574235 |
| 167 | muscle hypertrophy (GO:0014896) | 2.23139510 |
| 168 | macroautophagy (GO:0016236) | 2.22386890 |
| 169 | renal absorption (GO:0070293) | 2.21757117 |
| 170 | intestinal absorption (GO:0050892) | 2.20908363 |
| 171 | chemical homeostasis within a tissue (GO:0048875) | 2.20267816 |
| 172 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.19731219 |
| 173 | muscle hypertrophy in response to stress (GO:0003299) | 2.19731219 |
| 174 | cardiac muscle adaptation (GO:0014887) | 2.19731219 |
| 175 | surfactant homeostasis (GO:0043129) | 2.19478709 |
| 176 | tonic smooth muscle contraction (GO:0014820) | 2.17980791 |
| 177 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.16744294 |
| 178 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.15715417 |
| 179 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.15432970 |
| 180 | transcytosis (GO:0045056) | 2.15161689 |
| 181 | vascular smooth muscle contraction (GO:0014829) | 2.15065244 |
| 182 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.15032701 |
| 183 | glomerular filtration (GO:0003094) | 2.13904257 |
| 184 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.10540909 |
| 185 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.09683992 |
| 186 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.09270645 |
| 187 | regulation of heart rate (GO:0002027) | 2.08715632 |
| 188 | phosphate ion transmembrane transport (GO:0035435) | 2.08249184 |
| 189 | cGMP-mediated signaling (GO:0019934) | 2.06337259 |
| 190 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.04508872 |
| 191 | regulation of membrane repolarization (GO:0060306) | 2.03663290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.95592034 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.94476970 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.03362721 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.03183636 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.64628169 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.25170248 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.70156423 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.50732029 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.69887017 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.59885473 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.23198256 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12794685 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10888113 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.09674600 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.04327302 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99298184 |
| 17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.87600104 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84607621 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.77781040 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77488070 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70626200 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.60654212 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.55273494 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.52261650 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.49754810 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.49240840 |
| 27 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.48298397 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46154179 |
| 29 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46024537 |
| 30 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.41316586 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.40011623 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38383034 |
| 33 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.37974544 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35954791 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35745026 |
| 36 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34429927 |
| 37 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34399927 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33885031 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31685918 |
| 40 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29915132 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29086236 |
| 42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28553136 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26964305 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24410132 |
| 45 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24162675 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24162675 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23032217 |
| 48 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23032217 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21756015 |
| 50 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21409698 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19215600 |
| 52 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.18968248 |
| 53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16724208 |
| 54 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13628276 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13436455 |
| 56 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13242861 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12848752 |
| 58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11325117 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11321684 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11012120 |
| 61 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10162863 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10093268 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09489694 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09460468 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09142128 |
| 66 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08768663 |
| 67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07943623 |
| 68 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07365004 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07265819 |
| 70 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06907106 |
| 71 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06894434 |
| 72 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.06163284 |
| 73 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.05858204 |
| 74 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05022469 |
| 75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04614273 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04614273 |
| 77 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04456249 |
| 78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04399261 |
| 79 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.03995469 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03666130 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03350654 |
| 82 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02516706 |
| 83 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01576574 |
| 84 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00857417 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00832894 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99943732 |
| 87 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99859935 |
| 88 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99280140 |
| 89 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99253106 |
| 90 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99040710 |
| 91 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98832993 |
| 92 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98566772 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98398952 |
| 94 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97706283 |
| 95 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.96618688 |
| 96 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.96059254 |
| 97 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.95901495 |
| 98 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95664639 |
| 99 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95297627 |
| 100 | * AR_19668381_ChIP-Seq_PC3_Human | 0.95011625 |
| 101 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93693419 |
| 102 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92340593 |
| 103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.91444663 |
| 104 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88327469 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88189334 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87719000 |
| 107 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.87635995 |
| 108 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87461401 |
| 109 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83357936 |
| 110 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82751480 |
| 111 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82150154 |
| 112 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.80748607 |
| 113 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.79954694 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79918248 |
| 115 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.79835899 |
| 116 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76955305 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76617632 |
| 118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76252641 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75959453 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75622211 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75134821 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74257050 |
| 123 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.74093978 |
| 124 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73722622 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73598936 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.71870124 |
| 127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.69339986 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.69279293 |
| 129 | CBP_21632823_ChIP-Seq_H3396_Human | 0.67467990 |
| 130 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67326403 |
| 131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.66956451 |
| 132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.66829533 |
| 133 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.66667713 |
| 134 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.66015238 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64825432 |
| 136 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63964198 |
| 137 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.63950251 |
| 138 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62487283 |
| 139 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.62166511 |
| 140 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.61934633 |
| 141 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.61906886 |
| 142 | NFYA_21822215_ChIP-Seq_K562_Human | 0.61703874 |
| 143 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.61277613 |
| 144 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.60998966 |
| 145 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.60380051 |
| 146 | TBL1_22424771_ChIP-Seq_293T_Human | 0.60256887 |
| 147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.59601570 |
| 148 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58361265 |
| 149 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.57509925 |
| 150 | RXR_22108803_ChIP-Seq_LS180_Human | 0.56723797 |
| 151 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.56484623 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.56033766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.56042087 |
| 2 | MP0005360_urolithiasis | 6.02486375 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.49295693 |
| 4 | MP0005365_abnormal_bile_salt | 5.36497566 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.37375975 |
| 6 | MP0003252_abnormal_bile_duct | 3.61115937 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.23442829 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 3.23095360 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.05159381 |
| 10 | MP0005083_abnormal_biliary_tract | 2.85849648 |
| 11 | MP0009840_abnormal_foam_cell | 2.84249062 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.63670609 |
| 13 | MP0004270_analgesia | 2.60307300 |
| 14 | MP0005332_abnormal_amino_acid | 2.39965888 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.37833372 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.37238229 |
| 17 | MP0005451_abnormal_body_composition | 2.24974600 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.11310290 |
| 19 | MP0005409_darkened_coat_color | 1.92772196 |
| 20 | MP0003195_calcinosis | 1.84634675 |
| 21 | MP0000609_abnormal_liver_physiology | 1.84395821 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.84341069 |
| 23 | MP0004130_abnormal_muscle_cell | 1.77089849 |
| 24 | MP0003646_muscle_fatigue | 1.67567572 |
| 25 | MP0005670_abnormal_white_adipose | 1.65248094 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.60301953 |
| 27 | MP0003879_abnormal_hair_cell | 1.59981410 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.58277579 |
| 29 | MP0004036_abnormal_muscle_relaxation | 1.54948271 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.54011516 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.53097545 |
| 32 | MP0003868_abnormal_feces_composition | 1.45774683 |
| 33 | MP0000566_synostosis | 1.43096310 |
| 34 | MP0001486_abnormal_startle_reflex | 1.40522466 |
| 35 | MP0004185_abnormal_adipocyte_glucose | 1.38946467 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.35970052 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.35952451 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.33308155 |
| 39 | MP0004272_abnormal_basement_membrane | 1.32103836 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.28823011 |
| 41 | MP0003718_maternal_effect | 1.25956214 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.23649753 |
| 43 | MP0003690_abnormal_glial_cell | 1.23553027 |
| 44 | MP0004859_abnormal_synaptic_plasticity | 1.23225967 |
| 45 | MP0005369_muscle_phenotype | 1.23208251 |
| 46 | MP0002971_abnormal_brown_adipose | 1.22567071 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.21602073 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.20326501 |
| 49 | MP0002127_abnormal_cardiovascular_syste | 1.19726046 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.19212095 |
| 51 | MP0004215_abnormal_myocardial_fiber | 1.16741936 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.15051488 |
| 53 | MP0002272_abnormal_nervous_system | 1.14659699 |
| 54 | MP0001502_abnormal_circadian_rhythm | 1.14073665 |
| 55 | MP0006138_congestive_heart_failure | 1.13673791 |
| 56 | MP0005330_cardiomyopathy | 1.13552541 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.12963173 |
| 58 | MP0004233_abnormal_muscle_weight | 1.11006549 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.10935451 |
| 60 | MP0005647_abnormal_sex_gland | 1.10837259 |
| 61 | MP0000920_abnormal_myelination | 1.09209668 |
| 62 | MP0002108_abnormal_muscle_morphology | 1.08073017 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.07603118 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.07490094 |
| 65 | MP0002064_seizures | 1.06255815 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.05529375 |
| 67 | MP0001764_abnormal_homeostasis | 1.04218791 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.03945554 |
| 69 | MP0009384_cardiac_valve_regurgitation | 1.01129702 |
| 70 | MP0005408_hypopigmentation | 1.00127523 |
| 71 | MP0002972_abnormal_cardiac_muscle | 0.95750816 |
| 72 | MP0003635_abnormal_synaptic_transmissio | 0.95029028 |
| 73 | MP0000604_amyloidosis | 0.94086064 |
| 74 | MP0005620_abnormal_muscle_contractility | 0.93623655 |
| 75 | MP0009697_abnormal_copulation | 0.93573660 |
| 76 | MP0003329_amyloid_beta_deposits | 0.93371905 |
| 77 | MP0004087_abnormal_muscle_fiber | 0.93092274 |
| 78 | MP0003633_abnormal_nervous_system | 0.92760443 |
| 79 | MP0008569_lethality_at_weaning | 0.91958894 |
| 80 | MP0003950_abnormal_plasma_membrane | 0.91648527 |
| 81 | MP0009764_decreased_sensitivity_to | 0.91559691 |
| 82 | MP0001984_abnormal_olfaction | 0.90412597 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90277641 |
| 84 | MP0000579_abnormal_nail_morphology | 0.90247524 |
| 85 | MP0003186_abnormal_redox_activity | 0.90085202 |
| 86 | MP0005423_abnormal_somatic_nervous | 0.89802646 |
| 87 | MP0000598_abnormal_liver_morphology | 0.88871526 |
| 88 | MP0008775_abnormal_heart_ventricle | 0.88626274 |
| 89 | MP0004147_increased_porphyrin_level | 0.88546015 |
| 90 | MP0002876_abnormal_thyroid_physiology | 0.88537705 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.87563480 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.87246336 |
| 93 | MP0005187_abnormal_penis_morphology | 0.86294141 |
| 94 | MP0005395_other_phenotype | 0.83345696 |
| 95 | MP0009046_muscle_twitch | 0.83044569 |
| 96 | MP0000751_myopathy | 0.82873297 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.82733169 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.82633850 |
| 99 | MP0002063_abnormal_learning/memory/cond | 0.82440661 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.81643154 |
| 101 | MP0001544_abnormal_cardiovascular_syste | 0.81316418 |
| 102 | MP0005385_cardiovascular_system_phenoty | 0.81316418 |
| 103 | MP0000762_abnormal_tongue_morphology | 0.80392613 |
| 104 | MP0005375_adipose_tissue_phenotype | 0.79942479 |
| 105 | MP0010630_abnormal_cardiac_muscle | 0.79719618 |
| 106 | MP0004264_abnormal_extraembryonic_tissu | 0.79416120 |
| 107 | MP0001661_extended_life_span | 0.79125899 |
| 108 | MP0009763_increased_sensitivity_to | 0.78838926 |
| 109 | MP0009745_abnormal_behavioral_response | 0.78634218 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.75982520 |
| 111 | MP0000749_muscle_degeneration | 0.75913970 |
| 112 | MP0001664_abnormal_digestion | 0.75481391 |
| 113 | MP0002896_abnormal_bone_mineralization | 0.75154239 |
| 114 | MP0005646_abnormal_pituitary_gland | 0.74616393 |
| 115 | MP0000462_abnormal_digestive_system | 0.74093701 |
| 116 | MP0005334_abnormal_fat_pad | 0.73646542 |
| 117 | MP0003045_fibrosis | 0.72879552 |
| 118 | MP0002269_muscular_atrophy | 0.72169509 |
| 119 | MP0004924_abnormal_behavior | 0.71510622 |
| 120 | MP0005386_behavior/neurological_phenoty | 0.71510622 |
| 121 | MP0001756_abnormal_urination | 0.71436802 |
| 122 | MP0004043_abnormal_pH_regulation | 0.71108791 |
| 123 | MP0000383_abnormal_hair_follicle | 0.71084555 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.70496745 |
| 125 | MP0003631_nervous_system_phenotype | 0.69817381 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.68522270 |
| 127 | MP0009642_abnormal_blood_homeostasis | 0.68278736 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.67882869 |
| 129 | MP0004145_abnormal_muscle_electrophysio | 0.67776092 |
| 130 | MP0005535_abnormal_body_temperature | 0.67528633 |
| 131 | MP0005165_increased_susceptibility_to | 0.66826844 |
| 132 | MP0005636_abnormal_mineral_homeostasis | 0.66636937 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.66002572 |
| 134 | MP0004484_altered_response_of | 0.64871087 |
| 135 | MP0000747_muscle_weakness | 0.64767600 |
| 136 | MP0003011_delayed_dark_adaptation | 0.62390299 |
| 137 | MP0004883_abnormal_blood_vessel | 0.61165501 |
| 138 | MP0004085_abnormal_heartbeat | 0.61078560 |
| 139 | MP0003137_abnormal_impulse_conducting | 0.59619470 |
| 140 | MP0009115_abnormal_fat_cell | 0.56984512 |
| 141 | MP0003724_increased_susceptibility_to | 0.56444531 |
| 142 | MP0005266_abnormal_metabolism | 0.55146031 |
| 143 | MP0005084_abnormal_gallbladder_morpholo | 0.54135067 |
| 144 | MP0010234_abnormal_vibrissa_follicle | 0.52972947 |
| 145 | MP0003075_altered_response_to | 0.52944444 |
| 146 | MP0005595_abnormal_vascular_smooth | 0.52554658 |
| 147 | MP0002295_abnormal_pulmonary_circulatio | 0.52000911 |
| 148 | MP0000249_abnormal_blood_vessel | 0.51472608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.44265253 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.95334063 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.38050889 |
| 4 | Complement deficiency (HP:0004431) | 5.23263807 |
| 5 | Xanthomatosis (HP:0000991) | 5.21136709 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.85876525 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.69401231 |
| 8 | Bundle branch block (HP:0011710) | 4.63284959 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.52494325 |
| 10 | Hyperammonemia (HP:0001987) | 4.34342570 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 4.19212089 |
| 12 | Ketosis (HP:0001946) | 4.18343056 |
| 13 | Hyperglycinuria (HP:0003108) | 4.13926836 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 4.09623200 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.03263726 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.03263726 |
| 17 | Hyperglycinemia (HP:0002154) | 4.02669875 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.01276594 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.89134339 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.78155152 |
| 21 | Muscle fiber inclusion bodies (HP:0100299) | 3.75888724 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.68345642 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.66590570 |
| 24 | Epidermoid cyst (HP:0200040) | 3.64432552 |
| 25 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.56859787 |
| 26 | Nemaline bodies (HP:0003798) | 3.56023430 |
| 27 | Abnormality of complement system (HP:0005339) | 3.55857113 |
| 28 | Ketoacidosis (HP:0001993) | 3.48213022 |
| 29 | Joint hemorrhage (HP:0005261) | 3.46682382 |
| 30 | Fat malabsorption (HP:0002630) | 3.39032453 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.30727692 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.26745845 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.24427320 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.24108295 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.20378151 |
| 36 | EMG: myopathic abnormalities (HP:0003458) | 3.13845739 |
| 37 | Abnormality of the calf musculature (HP:0001430) | 3.07172666 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 3.04208437 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 3.02361923 |
| 40 | Heart block (HP:0012722) | 2.95976317 |
| 41 | Type 1 muscle fiber predominance (HP:0003803) | 2.92490179 |
| 42 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.85939908 |
| 43 | Atrial fibrillation (HP:0005110) | 2.85733635 |
| 44 | Hyperglycemia (HP:0003074) | 2.84994675 |
| 45 | Gout (HP:0001997) | 2.84967995 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.81944950 |
| 47 | Abnormal atrioventricular conduction (HP:0005150) | 2.81436022 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 2.76766825 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76766825 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.76573991 |
| 51 | Difficulty running (HP:0009046) | 2.75206858 |
| 52 | Calf muscle hypertrophy (HP:0008981) | 2.74919956 |
| 53 | Glomerulonephritis (HP:0000099) | 2.70919010 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.70917062 |
| 55 | Myocardial infarction (HP:0001658) | 2.66875874 |
| 56 | Skin nodule (HP:0200036) | 2.65866707 |
| 57 | Hyperkalemia (HP:0002153) | 2.63716166 |
| 58 | Ventricular fibrillation (HP:0001663) | 2.61608588 |
| 59 | Right ventricular cardiomyopathy (HP:0011663) | 2.60831854 |
| 60 | Subaortic stenosis (HP:0001682) | 2.60449488 |
| 61 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.60449488 |
| 62 | Abnormality of serum amino acid levels (HP:0003112) | 2.58521272 |
| 63 | Metabolic acidosis (HP:0001942) | 2.58006284 |
| 64 | Malnutrition (HP:0004395) | 2.57326390 |
| 65 | Steatorrhea (HP:0002570) | 2.51983445 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.50952036 |
| 67 | Amyloidosis (HP:0011034) | 2.49463098 |
| 68 | Distal lower limb muscle weakness (HP:0009053) | 2.47797388 |
| 69 | Neck muscle weakness (HP:0000467) | 2.47726317 |
| 70 | Action tremor (HP:0002345) | 2.46951570 |
| 71 | Primary atrial arrhythmia (HP:0001692) | 2.46295787 |
| 72 | Myoglobinuria (HP:0002913) | 2.39087449 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 2.37382697 |
| 74 | Hyperbilirubinemia (HP:0002904) | 2.36466871 |
| 75 | Sensorimotor neuropathy (HP:0007141) | 2.35174053 |
| 76 | Hepatocellular carcinoma (HP:0001402) | 2.34795535 |
| 77 | Cholelithiasis (HP:0001081) | 2.34654250 |
| 78 | Cholecystitis (HP:0001082) | 2.32892071 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.32892071 |
| 80 | Vascular calcification (HP:0004934) | 2.32637606 |
| 81 | Sudden death (HP:0001699) | 2.31843099 |
| 82 | Papillary thyroid carcinoma (HP:0002895) | 2.31029451 |
| 83 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.30572016 |
| 84 | Supraventricular tachycardia (HP:0004755) | 2.29517710 |
| 85 | Esophageal varix (HP:0002040) | 2.28600080 |
| 86 | Supraventricular arrhythmia (HP:0005115) | 2.28107735 |
| 87 | Dilated cardiomyopathy (HP:0001644) | 2.25885262 |
| 88 | Muscle fiber splitting (HP:0003555) | 2.25862952 |
| 89 | Exercise-induced myalgia (HP:0003738) | 2.23262192 |
| 90 | Dysmetric saccades (HP:0000641) | 2.19483326 |
| 91 | Lethargy (HP:0001254) | 2.19295718 |
| 92 | Lipoatrophy (HP:0100578) | 2.19255789 |
| 93 | Hyperactive renin-angiotensin system (HP:0000841) | 2.18819830 |
| 94 | EMG: neuropathic changes (HP:0003445) | 2.18619700 |
| 95 | Polycythemia (HP:0001901) | 2.16824433 |
| 96 | Generalized aminoaciduria (HP:0002909) | 2.16702103 |
| 97 | Delayed CNS myelination (HP:0002188) | 2.16535093 |
| 98 | Spontaneous abortion (HP:0005268) | 2.15363496 |
| 99 | Increased purine levels (HP:0004368) | 2.14116827 |
| 100 | Hyperuricemia (HP:0002149) | 2.14116827 |
| 101 | Ventricular tachycardia (HP:0004756) | 2.12807291 |
| 102 | Hemorrhage of the eye (HP:0011885) | 2.12216874 |
| 103 | Hypoglycemic seizures (HP:0002173) | 2.11596815 |
| 104 | Hyporeflexia of lower limbs (HP:0002600) | 2.10145199 |
| 105 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09946415 |
| 106 | Cardiovascular calcification (HP:0011915) | 2.09748678 |
| 107 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.08048563 |
| 108 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02643672 |
| 109 | Atrioventricular block (HP:0001678) | 2.01708136 |
| 110 | Exercise-induced muscle cramps (HP:0003710) | 2.01255075 |
| 111 | Syncope (HP:0001279) | 2.00885568 |
| 112 | Proximal tubulopathy (HP:0000114) | 2.00454736 |
| 113 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.99708127 |
| 114 | Cortical dysplasia (HP:0002539) | 1.98334886 |
| 115 | Decreased circulating renin level (HP:0003351) | 1.97857752 |
| 116 | Hypochromic microcytic anemia (HP:0004840) | 1.97741938 |
| 117 | Abnormality of the foot musculature (HP:0001436) | 1.94214777 |
| 118 | Late onset (HP:0003584) | 1.92968553 |
| 119 | Nephritis (HP:0000123) | 1.92844604 |
| 120 | Foot dorsiflexor weakness (HP:0009027) | 1.89736567 |
| 121 | Pancreatitis (HP:0001733) | 1.89724997 |
| 122 | Rhabdomyolysis (HP:0003201) | 1.89149535 |
| 123 | Irritability (HP:0000737) | 1.85541230 |
| 124 | Acanthocytosis (HP:0001927) | 1.85448437 |
| 125 | Increased connective tissue (HP:0009025) | 1.84116478 |
| 126 | Axonal loss (HP:0003447) | 1.83944402 |
| 127 | Ankle clonus (HP:0011448) | 1.83465817 |
| 128 | Myotonia (HP:0002486) | 1.83219699 |
| 129 | Febrile seizures (HP:0002373) | 1.83077133 |
| 130 | Vomiting (HP:0002013) | 1.82369292 |
| 131 | Distal arthrogryposis (HP:0005684) | 1.81657765 |
| 132 | Round ear (HP:0100830) | 1.81522595 |
| 133 | Frequent falls (HP:0002359) | 1.80526172 |
| 134 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.80130652 |
| 135 | Cerebral hemorrhage (HP:0001342) | 1.79664243 |
| 136 | Polar cataract (HP:0010696) | 1.79197472 |
| 137 | Scanning speech (HP:0002168) | 1.79192570 |
| 138 | Hydroxyprolinuria (HP:0003080) | 1.78886460 |
| 139 | Abnormality of proline metabolism (HP:0010907) | 1.78886460 |
| 140 | Abnormality of the gallbladder (HP:0005264) | 1.78727799 |
| 141 | Increased circulating renin level (HP:0000848) | 1.78468289 |
| 142 | Neurofibrillary tangles (HP:0002185) | 1.78406044 |
| 143 | Abnormality of renin-angiotensin system (HP:0000847) | 1.76942139 |
| 144 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.75692173 |
| 145 | Ventricular arrhythmia (HP:0004308) | 1.75354583 |
| 146 | Asymmetric septal hypertrophy (HP:0001670) | 1.73546041 |
| 147 | Hyperaldosteronism (HP:0000859) | 1.73337537 |
| 148 | Abnormal cartilage morphology (HP:0002763) | 1.72797757 |
| 149 | Blue irides (HP:0000635) | 1.72201189 |
| 150 | Limited hip movement (HP:0008800) | 1.70667495 |
| 151 | Neonatal death (HP:0003811) | 1.68348086 |
| 152 | Palpitations (HP:0001962) | 1.68321798 |
| 153 | Myopathic facies (HP:0002058) | 1.68271930 |
| 154 | Skin pits (HP:0100276) | 1.67764400 |
| 155 | Focal motor seizures (HP:0011153) | 1.67737367 |
| 156 | Lymphangioma (HP:0100764) | 1.67098025 |
| 157 | Visceral angiomatosis (HP:0100761) | 1.66415162 |
| 158 | Prolonged QT interval (HP:0001657) | 1.65072225 |
| 159 | Focal seizures (HP:0007359) | 1.64863626 |
| 160 | Rimmed vacuoles (HP:0003805) | 1.63712319 |
| 161 | Abnormality of potassium homeostasis (HP:0011042) | 1.62336956 |
| 162 | Alacrima (HP:0000522) | 1.61543816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 4.04299876 |
| 2 | BCKDK | 3.49369892 |
| 3 | TAOK3 | 3.43210030 |
| 4 | ERN1 | 2.52905867 |
| 5 | STK38L | 2.44507103 |
| 6 | TIE1 | 2.39278496 |
| 7 | NTRK3 | 2.20939879 |
| 8 | EPHB1 | 2.16881803 |
| 9 | ERBB4 | 2.16505218 |
| 10 | SIK1 | 2.14921725 |
| 11 | TRIB3 | 2.10072808 |
| 12 | LATS2 | 2.04842037 |
| 13 | MARK1 | 1.90798759 |
| 14 | INSRR | 1.88820404 |
| 15 | PDK2 | 1.87425179 |
| 16 | MAP3K6 | 1.77163964 |
| 17 | OBSCN | 1.75539348 |
| 18 | EPHA2 | 1.69955920 |
| 19 | LMTK2 | 1.65412798 |
| 20 | AKT3 | 1.65374721 |
| 21 | FGFR4 | 1.63671928 |
| 22 | PIK3CA | 1.63079400 |
| 23 | PRKAA2 | 1.61467518 |
| 24 | KSR2 | 1.61090458 |
| 25 | TGFBR2 | 1.61021360 |
| 26 | STK39 | 1.60488962 |
| 27 | MST1R | 1.58983815 |
| 28 | CAMK1D | 1.58896785 |
| 29 | PHKG1 | 1.50768879 |
| 30 | PHKG2 | 1.50768879 |
| 31 | PKN2 | 1.45428770 |
| 32 | MAP2K4 | 1.40854207 |
| 33 | RIPK1 | 1.39611784 |
| 34 | NEK6 | 1.36344845 |
| 35 | FGFR2 | 1.36310350 |
| 36 | DMPK | 1.33710061 |
| 37 | EPHA4 | 1.33530404 |
| 38 | CASK | 1.33489939 |
| 39 | PINK1 | 1.29420846 |
| 40 | TTN | 1.29211734 |
| 41 | FRK | 1.26132266 |
| 42 | MET | 1.22871940 |
| 43 | PRKAA1 | 1.21927930 |
| 44 | KDR | 1.15816024 |
| 45 | STK3 | 1.13497425 |
| 46 | CAMK1G | 1.13067812 |
| 47 | FGFR3 | 1.07761544 |
| 48 | EEF2K | 1.05465313 |
| 49 | PTK6 | 1.04835751 |
| 50 | MYLK | 1.03533141 |
| 51 | NEK9 | 1.01250131 |
| 52 | WNK4 | 0.99613787 |
| 53 | NTRK2 | 0.97596202 |
| 54 | OXSR1 | 0.97275745 |
| 55 | TAOK1 | 0.96732144 |
| 56 | CAMK2D | 0.96731851 |
| 57 | CAMK2B | 0.96715622 |
| 58 | RET | 0.94529918 |
| 59 | STK38 | 0.92715011 |
| 60 | PDK3 | 0.92288309 |
| 61 | PDK4 | 0.92288309 |
| 62 | MAPK11 | 0.91500403 |
| 63 | MAPK12 | 0.90167605 |
| 64 | PDPK1 | 0.89210114 |
| 65 | UHMK1 | 0.88840482 |
| 66 | SGK494 | 0.88760320 |
| 67 | SGK223 | 0.88760320 |
| 68 | ABL2 | 0.87614017 |
| 69 | PRKD1 | 0.86766943 |
| 70 | ICK | 0.84828332 |
| 71 | JAK2 | 0.83598585 |
| 72 | MAP3K12 | 0.82176490 |
| 73 | PIK3CG | 0.80418517 |
| 74 | CAMK2A | 0.78618981 |
| 75 | MAP2K3 | 0.78249792 |
| 76 | MAPK15 | 0.77805907 |
| 77 | MAP3K7 | 0.76908860 |
| 78 | ERBB3 | 0.76762889 |
| 79 | PRKCE | 0.75302013 |
| 80 | NTRK1 | 0.72938006 |
| 81 | PKN1 | 0.72564107 |
| 82 | CAMK4 | 0.70304826 |
| 83 | STK24 | 0.69145909 |
| 84 | SGK3 | 0.66929116 |
| 85 | BMPR1B | 0.66853198 |
| 86 | MAP3K2 | 0.65558388 |
| 87 | STK10 | 0.64384949 |
| 88 | CDK5 | 0.62832419 |
| 89 | PTK2 | 0.62577649 |
| 90 | ERBB2 | 0.61732046 |
| 91 | CAMK1 | 0.60870266 |
| 92 | TRPM7 | 0.59709816 |
| 93 | GSK3A | 0.57279182 |
| 94 | AKT2 | 0.56955211 |
| 95 | PRKG2 | 0.56793134 |
| 96 | WNK1 | 0.56646388 |
| 97 | PAK6 | 0.56347594 |
| 98 | SGK2 | 0.56346015 |
| 99 | SGK1 | 0.55991684 |
| 100 | MARK2 | 0.55860671 |
| 101 | PRKG1 | 0.55525645 |
| 102 | CDC42BPA | 0.55337327 |
| 103 | PAK3 | 0.55136229 |
| 104 | NLK | 0.54671516 |
| 105 | ROCK2 | 0.54019162 |
| 106 | TNIK | 0.53373595 |
| 107 | MELK | 0.53193768 |
| 108 | EPHA3 | 0.52721755 |
| 109 | MAPKAPK3 | 0.51999493 |
| 110 | PDK1 | 0.51005977 |
| 111 | PDGFRA | 0.50555036 |
| 112 | MAPK10 | 0.49860593 |
| 113 | MUSK | 0.49763966 |
| 114 | PNCK | 0.49634204 |
| 115 | JAK1 | 0.49514337 |
| 116 | RPS6KA3 | 0.49432822 |
| 117 | ACVR1B | 0.48713429 |
| 118 | CAMK2G | 0.48432047 |
| 119 | MTOR | 0.47928127 |
| 120 | CSNK1G1 | 0.47872419 |
| 121 | MAP2K2 | 0.47808712 |
| 122 | PRKD3 | 0.46668120 |
| 123 | MAP3K3 | 0.46254166 |
| 124 | CDK9 | 0.44322948 |
| 125 | DAPK2 | 0.43388273 |
| 126 | MAP2K1 | 0.41920390 |
| 127 | FER | 0.40856524 |
| 128 | ROCK1 | 0.40360227 |
| 129 | PDGFRB | 0.39476432 |
| 130 | MAP3K1 | 0.39347750 |
| 131 | PRKACG | 0.39195894 |
| 132 | PRKCZ | 0.37813122 |
| 133 | PRKACB | 0.37720796 |
| 134 | MOS | 0.37511203 |
| 135 | MAP3K5 | 0.37391747 |
| 136 | EPHB2 | 0.36415138 |
| 137 | MAPK4 | 0.34096242 |
| 138 | MAP3K9 | 0.34042904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.59945082 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53456008 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.81628327 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.81589881 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78319346 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72460654 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.68911698 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.47294986 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45329148 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45085051 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42497153 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.39606535 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.22612139 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22198386 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.16660582 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.03398352 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.89236084 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89170695 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.88553923 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85657116 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77011074 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76605849 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74917491 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70033161 |
| 25 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.59912643 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56993616 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55443292 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55439275 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55304184 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53344545 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.52246971 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50670557 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49421608 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42942788 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39452682 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33734365 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25934915 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25355716 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.25113131 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23953698 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.21408511 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.20726817 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20114320 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.18034285 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17680961 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16871901 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14737332 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11450010 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11387751 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.05400557 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05153370 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04765325 |
| 53 | Tight junction_Homo sapiens_hsa04530 | 1.03419297 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03079864 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 1.01376863 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99817684 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98178198 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97096880 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96175368 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95910885 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.95706948 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.93055103 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92844992 |
| 64 | GABAergic synapse_Homo sapiens_hsa04727 | 0.92727892 |
| 65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91809487 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91500576 |
| 67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90655698 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89597862 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88982044 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.88201196 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88114962 |
| 72 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87978022 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87866744 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.86567275 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84614787 |
| 76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.82059941 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79703668 |
| 78 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78502886 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75186537 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73897171 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69968754 |
| 82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69587213 |
| 83 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69216654 |
| 84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67784426 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67626447 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66980731 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.65555777 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63982966 |
| 89 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.62221099 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59228703 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.59040700 |
| 92 | Gap junction_Homo sapiens_hsa04540 | 0.58162431 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58148881 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57925057 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56742127 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56573641 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54601707 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53053796 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52518995 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.52102205 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51522835 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48939265 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48077497 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47617596 |
| 105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46587540 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45079228 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44554391 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43809729 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43223663 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35698156 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35352082 |
| 112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32202798 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30779041 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27910498 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.25997161 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25839340 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25743314 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22155764 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18170741 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.17683629 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17309544 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16941157 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16515959 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.11385676 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.10044085 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09863889 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.09836312 |
| 128 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08173880 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08079893 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06730466 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06615584 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.06250628 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.05506972 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05251612 |
| 135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.03587941 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | -0.0094960 |

